Essential Hypertension clinical trials
The registry lists 478 studies for Essential Hypertension across more than 10 countries. 74 are recruiting or about to start. 411 of them are mainly about Essential Hypertension (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its narrower condition Isolated Systolic Hypertension too: 510 studies, 80 open.
Get an email when these change. Save the Essential Hypertension studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
Boryung Pharmaceutical Co., Ltd (44) · Chong Kun Dang Pharmaceutical (18) · Takeda (15) · Novartis Pharmaceuticals (15) · Novartis (12) · Bayer (9) · Daiichi Sankyo (9) · Addpharma Inc. (8)
What is being tested here
Drugs under test in Essential Hypertension studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| BR1015 | 4 | 0 | 8 |
| Valsartan | 2 | 5 | 10 |
| Amlodipine | 1 | 19 | 33 |
| Hydrochlorothiazide | 1 | 11 | 17 |
| Olmesartan | 1 | 12 | 15 |
| Telmisartan | 1 | 1 | 6 |
| Sacubitril | 1 | 2 | 3 |
| AD-209 | 1 | 1 | 3 |
| Irbesartan | 1 | 1 | 3 |
| Eplerenone | 1 | 1 | 3 |
Drug classes tested here Angiotensin receptor blockers (ARBs) 5 open · Calcium channel blockers 1 open · Diuretics 1 open · Thiazide diuretics 1 open · Mineralocorticoid receptor antagonists (MRAs) 1 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Dec 2026A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy · Phase 3 · Boryung Pharmaceutical Co., Ltd
- Nov 2026REMIDEP-HTA Program for Hypertension Remission and Medication Deprescription · Evelyn Vanina Re
- Nov 2026Smartphone-Guided Paced Breathing and Aerobic Exercise for Essential Hypertension · Cairo University
- Dec 2026BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT · Orchestra BioMed, Inc
- Dec 2026Mobile Health Program for Rural Hypertension · University of Pittsburgh
- Dec 2026The Effect of Self-Acupressure on Blood Pressure, Stress, and Well-Being Levels in Individuals With Hypertension · Abant Izzet Baysal University
- Dec 2026To Evaluate the Efficacy and Safety of KN060 in Essential Hypertension · Suzhou Alphamab Co., Ltd.
- Dec 2026Circadian Disruption And Cardiovascular Risk In Young Adults With Hypertension · Medical University of Sofia
- Jan 2027Effect of Meditation as an Adjunct to Cardiac Rehabilitation · Instituto Dante Pazzanese de Cardiologia
- Feb 2027A Study of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 in Patients With Essential Hypertension · Boryung Pharmaceutical Co., Ltd
Who these studies take
Of the 43 Essential Hypertension studies recruiting now, 15 (35%) set no upper age limit and 20 (47%) stop at 75 or younger. 4 (9%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 11 (26%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 4 (9%) | 4 (9%) |
| 18 | 25 (58%) | 25 (58%) |
| 30 | 37 (86%) | 37 (86%) |
| 40 | 38 (88%) | 38 (88%) |
| 50 | 39 (91%) | 39 (91%) |
| 65 | 39 (91%) | 39 (91%) |
| 75 | 31 (72%) | 31 (72%) |
| 85 | 19 (44%) | 19 (44%) |
Across all 478 studies, recruiting or not: 45% stop at 75 or younger and 23% at 65; 5% take children; 1% are for women only and 5% for men only; 21% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Essential Hypertension studies take
Of 47 phase 3 interventional studies under Essential Hypertension, half reached primary completion within 17 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 2 mo1–8 · 18 studies | — | — |
| Phase 2 | 17 mo9–40 · 15 studies | — | — |
| Phase 3 | 17 mo11–24 · 47 studies | 16 mo11–24 · 45 studies | — |
| Phase 4 | 24 mo18–36 · 22 studies | — | — |
| Interventional, no phase | 20 mo8–48 · 80 studies | — | 16 mo7–47 · 70 studies |
| Observational | 44 mo27–52 · 26 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 13, 2026.
Started recruiting1
Newly registered3
- A Study to Evaluate the Effectiveness and Safety of S-amlodipine-based Monotherapy and Combination TherapyOct 30, 2026NCT07907822
- Text Message Support to Help Adults With Newly Diagnosed High Blood Pressure Control Their Blood Pressure in Primary Care Clinics in Germany and PakistanOct 16, 2026NCT07878728
- Monitoring the Effectiveness and Safety of Antihypertensive Therapy With a Fixed-Dose Combination of Perindopril and Amlodipine in Patients With Uncontrolled Essential HypertensionOct 15, 2026NCT07876895
Studies
Recruiting first, then most recently updated. Showing 50 of 478. Browse all 478 → or search them.
- The Effect of Self-Acupressure on Blood Pressure, Stress, and Well-Being Levels in Individuals With HypertensionRecruitingNCT07577973Not applicable1 country
- A Study to Evaluate the Effectiveness and Safety of S-amlodipine-based Monotherapy and Combination TherapyNot yet recruitingNCT07907822
- Isometric Resistance Exercise on Accelerated Atherosclerosis in HypertensionRecruitingNCT07665034Not applicable1 country
- Global Paradise System US Post Approval StudyRecruitingNCT062972911 country
- A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination TherapyRecruitingNCT06220773Phase 32 countries
- Effects of Isometric Wall Squat Training on Blood Pressure in Adults With HypertensionRecruitingNCT07868822Not applicable1 country
- Instructor Interpersonal Behaviours in Classical Pilates as a Pathway to Improve Blood Pressure Control and Well-being in Hypertensive AdultsNot yet recruitingNCT07860437Not applicable1 country
- Sacubitril/Valsartan Versus Valsartan Alone on Left Atrial Volume Index in Hypertensive PatientsNot yet recruitingNCT07853625Not applicable
- BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenTRecruitingNCT06059638Not applicable15 countries
- Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With HypertensionRecruitingNCT07607275Phase 41 country
- Phase 1 Clinical Study of MWX401 Injection in Chinese Healthy Participants and Participants With Mild HypertensionRecruitingNCT07803835Phase 11 country
- Childhood-Onset Essential Hypertension Natural History StudyRecruitingNCT067782391 country
- Effect of Meditation as an Adjunct to Cardiac RehabilitationRecruitingNCT07310992Not applicable1 country
- Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)Not yet recruitingNCT07083765Phase 31 country
- Safety and Efficacy of Remote Ischemic Conditioning Treatment for Community-based Essential HypertensionRecruitingNCT03945305Not applicable1 country
- Endothelial Extracellular Vesicles as Biomarkers of Endothelial Activation in Children With Newly Diagnosed HypertensionRecruitingNCT077286431 country
- Endothelial Extracellular Vesicles as Biomarkers of Endothelial Activation in Adults With Newly Diagnosed HypertensionRecruitingNCT077286301 country
- Evaluating the Effects of a Mindfulness Intervention on Health Outcomes in Individuals With HypertensionNot yet recruitingNCT07679984Not applicable1 country
- To Evaluate the Renal Protective Effects and Safety of 'Fimasartan and Atorvastatin' or 'Fimasartan, Atorvastatin and Ezetimibe'.Not yet recruitingNCT07685054
- Study of KK3910 in Healthy Volunteers and Patients With Essential HypertensionRecruitingNCT06823947Phase 11 country
- Optical Coherence Tomography Angiography in Subjects With Retinal Vascular DiseaseRecruitingNCT04505618Not applicable1 country
- Safety and Efficacy Evaluation of Non-invasive Temporal Interference Stimulation for Blood Pressure Modulation in Patients With Mild Essential HypertensionNot yet recruitingNCT07577323Not applicable1 country
- Dietary Nitrate and the Oral Microbiome in Children With Primary HypertensionRecruitingNCT072361251 country
- High-Intensity Transcranial Alternating Current Stimulation (Hi-tACS) for Hypertension: A Randomized Controlled TrialNot yet recruitingNCT07566650Not applicable1 country
- Bioequivalence Study of Sacubitril Alisartan Amlodipine TabletsNot yet recruitingNCT07486453Phase 11 country
- REMIDEP-HTA Program for Hypertension Remission and Medication DeprescriptionNot yet recruitingNCT07424118Not applicable1 country
- A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-1 and BR1015-2 Under Fed ConditionsNot yet recruitingNCT07421388Phase 1
- A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fed ConditionsNot yet recruitingNCT07421414Phase 1
- A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-1 and BR1015-2 Under Fasting ConditionsNot yet recruitingNCT07421375Phase 1
- A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fasting ConditionsNot yet recruitingNCT07421401Phase 1
- Engaging Home-monitored Assessment to Navigate Clinical Decision-makingEnrolling by invitationNCT07399912Not applicable1 country
- Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood PressureRecruitingNCT07383220Not applicable1 country
- A Study of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 in Patients With Essential HypertensionNot yet recruitingNCT07373613Phase 21 country
- The Effect of Motivational Interviewing on Knowledge, Self-Efficacy, and Treatment Adherence in Patients With Primary Hypertension Living in Semi-Rural AreasEnrolling by invitationNCT07307924Not applicable1 country
- Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202ARecruitingNCT06643819Phase 31 country
- Mobile Health Program for Rural HypertensionRecruitingNCT05546931Not applicable1 country
- The Effect of Lavender Inhalation on Anxiety, Sleep, and Blood PressureRecruitingNCT07192783Not applicable1 country
- To Evaluate the Efficacy and Safety of KN060 in Essential HypertensionRecruitingNCT07191899Phase 11 country
- The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through NatureRecruitingNCT050679981 country
- An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZRecruitingNCT054130571 country
- To Evaluate the Safety and Efficacy of a Single-Use IVUS Ablation for Primary HypertensionRecruitingNCT07051811Not applicable1 country
- Automatic and Conventional Methods of Hypertensive Patients MonitoringNot yet recruitingNCT06929728
- A Phase III Clinical Study of Valsartan Oral Solution for the Treatment of Hypertension in Children and AdolescentsEnrolling by invitationNCT06863987Phase 31 country
- Improving Hypertension Control in CHina and ARGEntina With a Mobile APP-based Telecare SystemRecruitingNCT03206814Not applicable2 countries
- Efficacy and Safety of SPC1001 in Patients With Essential HypertensionRecruitingNCT06826872Phase 21 country
- A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227BRecruitingNCT06441630Phase 31 country
- A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive PatientsNot yet recruitingNCT06771245Phase 3
- QR12000 Compound Tablets in Patients with Moderate to Severe Essential HypertensionNot yet recruitingNCT06716970Phase 31 country
- Effects of Remote Ischemic Conditioning on Blood Pressure in Older Patients With HypertensionRecruitingNCT05845905Not applicable1 country
- Investigation of the Effect of Mobile Software Use in Blood Pressure Management of Hypertensive Individuals on Quality of Life and Disease Self-EfficacyRecruitingNCT06321159Not applicable1 country